Mode
Text Size
Log in / Sign up
N/A Completed N=205 Treatment

Stryker Triathlon Total Knee System for Total Knee Arthroplasty Implanted Using ShapeMatch® Cutting Guides: Sub-Study B

Arthroplasties, Replacement, Knee
Source: ClinicalTrials.gov NCT02527161 ↗
Enrolled (actual)
205
Serious AEs
50.0%
Results posted
Oct 2015
Primary outcomePrimary: Implant Location/Assessment of Alignment — 1.70; 1.91 degrees — p=<0.001

Summary

This is a prospective, non-randomized, longitudinal study of the clinical outcomes of participants that receive the Stryker Triathlon® Total Knee System for Total Knee Arthroplasty implanted using ShapeMatch® Cutting Guides. Health status and functional outcome measures will be recorded to quantify functional status of subjects before surgery and at each follow-up interval. This sub-study involved the assessment of the placement of the ShapeMatch® Cutting Guides intraoperatively and post-operatively. An assessment of post-operative patient outcomes compared to pre-operative status was also analysed.

Outcome Measures

OutcomeResultp-value
PRIMARY
Implant Location/Assessment of Alignment
1.70; 1.91 <0.001 sig
SECONDARY
Knee Injury and Osteoarthritis Outcome Score (KOOS)_Pain
36.18; 66.23; 74.96; 80.03; 85.11; 87.00 <0.0001 sig
SECONDARY
Knee Injury and Osteoarthritis Outcome Score (KOOS)_Symptoms
40.94; 64.78; 71.12; 75.16; 83.12; 84.49 <0.0001 sig
SECONDARY
Knee Injury and Osteoarthritis Outcome Score (KOOS)_ADL
38.08; 71.98; 78.75; 82.37; 88.14; 89.60 <0.0001 sig
SECONDARY
Knee Injury and Osteoarthritis Outcome Score (KOOS)_S&R
14.45; 65.05; 65.92; 64.78; 39.06; 48.58 <0.0001 sig
SECONDARY
Knee Injury and Osteoarthritis Outcome Score (KOOS)_QOL
19.92; 51.87; 61.51; 69.44; 77.09; 79.82 <0.0001 sig
SECONDARY
Short Form Health Survey 12 v2 (SF-12)_Physical Component Summary (PCS)
34.36; 40.27; 45.99; 47.35; 48.27; 49.90 <0.0001 sig
SECONDARY
VAS Pain at Rest
5.78; 3.09; 2.02; 1.45; 1.22; 1.09 <0.0001 sig
SECONDARY
VAS Pain Mobilised
7.28; 3.47; 2.39; 1.83; 1.43; 1.41 <0.0001 sig
SECONDARY
Short Form Health Survey 12 (SF-12)_Mental Component Summary (MCS)
47.02; 49.91; 52.18; 52.58; 52.93; 52.78 0.3493
SECONDARY
Knee Society Clinical Rating System (KSS) Pain Scores
32.95; 69.05; 71.36; 76.75; 78.04; 75.60 <0.0001 sig
SECONDARY
Knee Society Clinical Rating System (KSS) Functional Scores
43.45; 66.82; 75.45; 76.99; 74.82; 71.44 <0.0001 sig
SECONDARY
Knee Society Clinical Rating System (KSS) Range of Motion Scores
108.59; 110.40; 112.71; 115.30; 115.09; 119.11 0.8581
SECONDARY
Forgotten Joint Score (FJS)
54.48; 40.28; 68.82 0.0161 sig

Eligibility Criteria

Inclusion Criteria

  • The patient is a male or non-pregnant female between the ages of 50-90.
  • The patient requires a primary total knee replacement and is indicated for computer-assisted surgery.
  • The patient has a primary diagnosis of osteoarthritis (OA).
  • The patient has intact collateral ligaments.
  • The patient is able to undergo MRI scanning of the affected limb.
  • The patient has signed the study specific, HREC-approved, Informed Consent document.
  • The patient is willing and able to comply with the specified pre-operative and post-operative clinical and radiographic evaluations.

Exclusion Criteria

  • The patient has a history of total, unicompartmental reconstruction or fusion of the affected joint.
  • The patient has had a high tibial osteotomy or femoral osteotomy.
  • The patient is morbidly obese (BMI ≥ 40).
  • The patient has a deformity which will require the use of stems, wedges or augments in conjunction with the Triathlon Total Knee System.
  • The patient has a varus/valgus malalignment ≥ 15° (relative to mechanical axis).
  • The patient has a fixed flexion deformity ≥ 15°.
  • The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
  • The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
  • The patient has a cognitive impairment, an intellectual disability or a mental illness.
  • The patient is pregnant.
  • The patient has metal hardware present in the region of the hip, knee or ankle (as this is known to create geometrical distortion in the region of the implant).
  • The patient has any known contraindications for undergoing assessment by MRI (e.g. ferrous implants, metallic clips, magnetically activated implanted devices such as cardiac pacemakers, etc).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02527161). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search